LT1001
Postoperative Pain
MarketActive
Key Facts
About Lumosa Therapeutics
Taiwan biotech advancing breakthrough stroke and pain therapies with a strong licensing and co‑development model.
View full company profileTherapeutic Areas
Other Postoperative Pain Drugs
| Drug | Company | Phase |
|---|---|---|
| Alevatrix™ | Rebel Medicine | IND-enabling |
| SBG004 | Sonoran Biosciences | Pre-clinical/Phase 1 |
| TT5 | Tafalgie Therapeutics | Phase 1 |